1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Primate Diseases in 2 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Primate Diseases: Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakowec, MW | 1 |
| Petzinger, GM | 1 |
| Bankiewicz, KS | 1 |
| Forsayeth, J | 1 |
| Eberling, JL | 1 |
| Sanchez-Pernaute, R | 1 |
| Pivirotto, P | 1 |
| Bringas, J | 1 |
| Herscovitch, P | 1 |
| Carson, RE | 1 |
| Eckelman, W | 1 |
| Reutter, B | 1 |
| Cunningham, J | 1 |
1 review available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Primate Diseases
| Article | Year |
|---|---|
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine Agents; Huma | 2004 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Primate Diseases
| Article | Year |
|---|---|
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavio | 2006 |